The Development of an Antimicrobial Contact Lens - From the Laboratory to the Clinic.


Journal

Current protein & peptide science
ISSN: 1875-5550
Titre abrégé: Curr Protein Pept Sci
Pays: United Arab Emirates
ID NLM: 100960529

Informations de publication

Date de publication:
2020
Historique:
received: 10 04 2019
revised: 14 06 2019
accepted: 22 07 2019
pubmed: 21 8 2019
medline: 6 1 2021
entrez: 21 8 2019
Statut: ppublish

Résumé

Contact lens wear is generally safe and provides excellent vision. However, contact lens wear is often associated with the risk of developing ocular surface infection and inflammation, and in severe cases, the infection can result in loss of vision. Antimicrobial peptide-coated contact lenses have been made to help reduce the incidence of infection and inflammation. This paper reviews the research progress from conception, through the laboratory and preclinical tests to the latest information on clinical testing of an antimicrobial contact lens. We provide insights into the pathways followed and pitfalls that have been encountered. The journey has not always been linear or smooth, but has resulted in some of the first published clinical testing of antimicrobial peptide-coated contact lenses in humans. We hope this may help lead to the development and commercialisation of antimicrobial contact lenses in the future.

Identifiants

pubmed: 31429686
pii: CPPS-EPUB-100360
doi: 10.2174/1389203720666190820152508
doi:

Substances chimiques

Anti-Infective Agents 0
Antimicrobial Cationic Peptides 0
Coated Materials, Biocompatible 0
melimine 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

357-368

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Mark D P Willcox (MDP)

School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.

R Chen (R)

School of Chemistry, University of New South Wales, Sydney, Australia.

P Kalaiselvan (P)

School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.

M Yasir (M)

School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.

R Rasul (R)

School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.

N Kumar (N)

School of Chemistry, University of New South Wales, Sydney, Australia.

D Dutta (D)

School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH